O. Q. Yin

Associations of the CYP3A5*3 and CYP3A4*1G polymorphisms with the pharmacokinetics of oral midazolam and the urinary 6β‐hydroxycortisol/cortisol ratio as markers of CYP3A activity in healthy male Chinese

B. Tomlinson, S. Chan, O. Yin, 2016, Journal of clinical pharmacy and therapeutics.

Effects of combined CYP2C9 and 2C19 polymorphism on the pharmacokinetics of glibenclamide in Chinese subjects

B. Tomlinson, M. Chow, O. Q. Yin, 2005 .

CYP3A5 but Not CYP2D6 Polymorphism Contributes Significantly to the Variability in Dextropropoxyphene Disposition

B. Tomlinson, M. Chow, O. Yin, 2010, Journal of clinical pharmacology.

Population Pharmacokinetics of Cyclosporine in Chinese Cardiac Transplant Recipients

M. Chow, O. Yin, Sophia Lau, 2006, Pharmacotherapy.

CYP2C9, but not CYP2C19, polymorphisms affect the pharmacokinetics and pharmacodynamics of glyburide in Chinese subjects

B. Tomlinson, M. Chow, O. Yin, 2005, Clinical pharmacology and therapeutics.

Variability in Renal Clearance of Substrates for Renal Transporters in Chinese Subjects

B. Tomlinson, M. Chow, O. Yin, 2006, Journal of clinical pharmacology.